BiotechTube

AMG 386 + AMG 386 Placebo + Paclitaxel + Paclitaxel

Phase 3Completed
0 views this week 0 watching⚡ Active
Interest: 40/100
40
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Fallopian Tube Cancer

Conditions

Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer

Trial Timeline

Nov 1, 2010 → Dec 1, 2016

NCT ID
NCT01204749

About AMG 386 + AMG 386 Placebo + Paclitaxel + Paclitaxel

AMG 386 + AMG 386 Placebo + Paclitaxel + Paclitaxel is a phase 3 stage product being developed by Amgen for Fallopian Tube Cancer. The current trial status is completed. This product is registered under clinical trial identifier NCT01204749. Target conditions include Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cancer.

What happened to similar drugs?

0 of 3 similar drugs in Fallopian Tube Cancer were approved

Approved (0) Terminated (2) Active (1)
🔄Carboplatin + Cediranib Maleate + Gemcitabine + Gemcitabine Hydrochloride + Olaparib + Paclitaxel + Pegylated Liposomal Doxorubicin HydrochlorideAstraZenecaPhase 3
❌AMG386 plus PLD + Placebo plus PLDAmgenPhase 3
❌AMG 386 + Paclitaxel + AMG 386 Placebo + CarboplatinAmgenPhase 3

Hype Score Breakdown

Clinical
17
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT01204749Phase 3Completed

Competing Products

20 competing products in Fallopian Tube Cancer

See all competitors
ProductCompanyStageHype Score
PRGN-3005 UltraCAR-T cells + PRGN-3005 UltraCAR-T cellsPrecigenPhase 1
27
azenosertibZentalis PharmaceuticalsPhase 2
32
exatecan mesylateDaiichi SankyoPhase 2
35
Lenvatinib Mesylate + PaclitaxelEisaiPhase 1
29
decitabine + NY-ESO-1 peptide vaccine + pegylated liposomal doxorubicin hydrochloride + sargramostim + incomplete Freund's adjuvantEisaiPhase 1
29
ABT-767AbbViePhase 1
29
Batiraxcept + DurvalumabAstraZenecaPhase 1/2
24
Carboplatin + Cediranib Maleate + Gemcitabine + Gemcitabine Hydrochloride + Olaparib + Paclitaxel + Pegylated Liposomal Doxorubicin HydrochlorideAstraZenecaPhase 3
44
Adavosertib + Paclitaxel + Carboplatin + Gemcitabine + PLDAstraZenecaPhase 2
35
plevitrexed + topotecan hydrochlorideAstraZenecaPhase 2
35
Entinostat + OlaparibAstraZenecaPhase 1
21
AZD5335 + ItraconazoleAstraZenecaPhase 1
36
PembrolizumabMerckPhase 2
39
Carboplatin + PembrolizumabMerckPhase 1/2
32
Guadecitabine + PembrolizumabMerckPhase 2
35
recombinant adenovirus-p53 SCH-58500MerckPhase 1
29
Pembrolizumab + Paclitaxel + CarboplatinMerckPhase 2
27
AMG386 plus PLD + Placebo plus PLDAmgenPhase 3
32
AMG 386 + Paclitaxel + AMG 386 Placebo + CarboplatinAmgenPhase 3
32
PF-06873600 + Endocrine Therapy 1 + Endocrine Therapy 2PfizerPhase 1/2
24